Gene Symbol | Gene ID | Gene Info |
---|---|---|
ELK4
|
ENSG00000158711.9 | ETS transcription factor ELK4 |
ETV5
|
ENSG00000244405.3 | ETS variant transcription factor 5 |
ELK1
|
ENSG00000126767.13 | ETS transcription factor ELK1 |
ELK3
|
ENSG00000111145.3 | ETS transcription factor ELK3 |
ELF4
|
ENSG00000102034.12 | E74 like ETS transcription factor 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_129254911_129255250 | ELF4 | 10389 | 0.194024 | 0.63 | 6.9e-02 | Click! |
chrX_129217430_129217581 | ELF4 | 26831 | 0.177081 | 0.63 | 7.1e-02 | Click! |
chrX_129240382_129240549 | ELF4 | 3871 | 0.249749 | 0.61 | 8.1e-02 | Click! |
chrX_129238691_129238842 | ELF4 | 5570 | 0.226962 | -0.60 | 8.4e-02 | Click! |
chrX_129252830_129253029 | ELF4 | 8238 | 0.201841 | -0.60 | 8.5e-02 | Click! |
chrX_47509630_47509946 | ELK1 | 99 | 0.947969 | 0.88 | 1.8e-03 | Click! |
chrX_47509270_47509465 | ELK1 | 520 | 0.680017 | 0.61 | 8.1e-02 | Click! |
chrX_47508576_47509160 | ELK1 | 1019 | 0.405099 | 0.38 | 3.2e-01 | Click! |
chrX_47510164_47510912 | ELK1 | 535 | 0.669111 | 0.21 | 5.8e-01 | Click! |
chrX_47507369_47507520 | ELK1 | 2443 | 0.185152 | 0.14 | 7.2e-01 | Click! |
chr12_96588291_96588464 | ELK3 | 15 | 0.980718 | 0.61 | 8.4e-02 | Click! |
chr12_96589832_96590082 | ELK3 | 1565 | 0.418213 | 0.48 | 1.9e-01 | Click! |
chr12_96580571_96580722 | ELK3 | 7514 | 0.216519 | -0.46 | 2.1e-01 | Click! |
chr12_96580128_96580279 | ELK3 | 7957 | 0.214861 | -0.41 | 2.7e-01 | Click! |
chr12_96592115_96592322 | ELK3 | 3826 | 0.248309 | -0.39 | 3.0e-01 | Click! |
chr1_205601139_205601661 | ELK4 | 310 | 0.878554 | 0.60 | 8.7e-02 | Click! |
chr1_205599880_205600585 | ELK4 | 858 | 0.562561 | 0.59 | 9.4e-02 | Click! |
chr1_205600717_205600868 | ELK4 | 298 | 0.884914 | 0.47 | 2.0e-01 | Click! |
chr1_205605987_205606138 | ELK4 | 4972 | 0.180059 | -0.25 | 5.2e-01 | Click! |
chr1_205599470_205599752 | ELK4 | 1479 | 0.360255 | 0.23 | 5.5e-01 | Click! |
chr3_185823332_185823483 | ETV5 | 2926 | 0.305018 | -0.66 | 5.1e-02 | Click! |
chr3_185902929_185903080 | ETV5 | 74897 | 0.098653 | -0.56 | 1.2e-01 | Click! |
chr3_185826921_185827162 | ETV5 | 140 | 0.969312 | 0.56 | 1.2e-01 | Click! |
chr3_185825097_185825248 | ETV5 | 1161 | 0.554380 | -0.55 | 1.3e-01 | Click! |
chr3_185869306_185869457 | ETV5 | 41274 | 0.169603 | 0.51 | 1.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chrY_2709555_2710183 | 5.71 |
RPS4Y1 |
ribosomal protein S4, Y-linked 1 |
92 |
0.98 |
chr22_31556003_31556177 | 5.33 |
ENSG00000264141 |
. |
15 |
0.54 |
chr7_139024892_139025088 | 4.70 |
C7orf55-LUC7L2 |
C7orf55-LUC7L2 readthrough |
115 |
0.89 |
chr13_74339708_74339938 | 4.48 |
KLF12 |
Kruppel-like factor 12 |
229363 |
0.02 |
chr2_8628153_8628374 | 4.33 |
AC011747.7 |
|
187633 |
0.03 |
chr9_132404432_132404583 | 4.30 |
ASB6 |
ankyrin repeat and SOCS box containing 6 |
63 |
0.95 |
chr20_45318051_45318277 | 4.15 |
TP53RK |
TP53 regulating kinase |
85 |
0.97 |
chr3_131221719_131221870 | 4.04 |
MRPL3 |
mitochondrial ribosomal protein L3 |
1 |
0.98 |
chr22_50987100_50987359 | 4.02 |
KLHDC7B |
kelch domain containing 7B |
767 |
0.36 |
chr20_43104579_43105071 | 3.97 |
TTPAL |
tocopherol (alpha) transfer protein-like |
265 |
0.86 |
chr7_75250499_75250650 | 3.92 |
HIP1 |
huntingtin interacting protein 1 |
9413 |
0.2 |
chr5_148724892_148725043 | 3.91 |
GRPEL2 |
GrpE-like 2, mitochondrial (E. coli) |
26 |
0.96 |
chr3_194277134_194277288 | 3.85 |
ENSG00000252053 |
. |
22899 |
0.12 |
chr12_47609896_47610314 | 3.75 |
PCED1B |
PC-esterase domain containing 1B |
53 |
0.98 |
chrX_4159106_4159257 | 3.74 |
ENSG00000264861 |
. |
342360 |
0.01 |
chr10_43277722_43278243 | 3.73 |
BMS1 |
BMS1 ribosome biogenesis factor |
267 |
0.93 |
chr10_97889836_97890188 | 3.70 |
ENSG00000200728 |
. |
17508 |
0.19 |
chr7_50132724_50132936 | 3.58 |
ZPBP |
zona pellucida binding protein |
2 |
0.98 |
chr7_140104210_140104460 | 3.42 |
SLC37A3 |
solute carrier family 37, member 3 |
225 |
0.73 |
chrX_1324594_1325309 | 3.41 |
CRLF2 |
cytokine receptor-like factor 2 |
6576 |
0.2 |
chr13_110993415_110993566 | 3.39 |
COL4A2 |
collagen, type IV, alpha 2 |
33876 |
0.17 |
chr3_44666133_44666563 | 3.38 |
ZNF197-AS1 |
ZNF197 antisense RNA 1 |
59 |
0.64 |
chr19_48752803_48753145 | 3.36 |
CARD8 |
caspase recruitment domain family, member 8 |
49 |
0.96 |
chr14_22977741_22978031 | 3.34 |
TRAJ15 |
T cell receptor alpha joining 15 |
20694 |
0.09 |
chr1_167483926_167484083 | 3.30 |
CD247 |
CD247 molecule |
3771 |
0.25 |
chr11_15096182_15096333 | 3.28 |
CALCB |
calcitonin-related polypeptide beta |
1149 |
0.59 |
chr2_204192770_204192939 | 3.24 |
ABI2 |
abl-interactor 2 |
88 |
0.95 |
chr7_105494613_105494850 | 3.22 |
ATXN7L1 |
ataxin 7-like 1 |
22192 |
0.26 |
chr17_19280958_19281479 | 3.20 |
B9D1 |
B9 protein domain 1 |
15 |
0.65 |
chr5_175123540_175123739 | 3.18 |
ENSG00000200648 |
. |
7262 |
0.21 |
chr19_56632546_56632905 | 3.11 |
ZNF787 |
zinc finger protein 787 |
76 |
0.96 |
chr14_22950797_22950948 | 3.05 |
TRAJ55 |
T cell receptor alpha joining 55 (pseudogene) |
186 |
0.79 |
chr16_58058806_58059040 | 3.05 |
MMP15 |
matrix metallopeptidase 15 (membrane-inserted) |
547 |
0.69 |
chr18_59221687_59221979 | 3.01 |
CDH20 |
cadherin 20, type 2 |
4734 |
0.36 |
chr6_8182388_8182539 | 3.00 |
EEF1E1 |
eukaryotic translation elongation factor 1 epsilon 1 |
79652 |
0.11 |
chr2_225449599_225449800 | 3.00 |
CUL3 |
cullin 3 |
366 |
0.93 |
chr2_242556723_242557374 | 2.98 |
THAP4 |
THAP domain containing 4 |
132 |
0.94 |
chr2_234327510_234328202 | 2.95 |
DGKD |
diacylglycerol kinase, delta 130kDa |
31056 |
0.14 |
chr18_13464907_13465379 | 2.94 |
LDLRAD4 |
low density lipoprotein receptor class A domain containing 4 |
129 |
0.93 |
chr8_125576964_125577180 | 2.94 |
MTSS1 |
metastasis suppressor 1 |
896 |
0.54 |
chr19_10346719_10347362 | 2.94 |
DNMT1 |
DNA (cytosine-5-)-methyltransferase 1 |
5078 |
0.09 |
chrX_7895535_7895957 | 2.93 |
PNPLA4 |
patatin-like phospholipase domain containing 4 |
34 |
0.99 |
chr3_52321810_52322234 | 2.92 |
WDR82 |
WD repeat domain 82 |
14 |
0.64 |
chr19_13215215_13215439 | 2.89 |
LYL1 |
lymphoblastic leukemia derived sequence 1 |
1352 |
0.27 |
chr22_17700031_17700512 | 2.89 |
CECR1 |
cat eye syndrome chromosome region, candidate 1 |
5 |
0.98 |
chr20_34824331_34824679 | 2.89 |
AAR2 |
AAR2 splicing factor homolog (S. cerevisiae) |
98 |
0.97 |
chr2_70120787_70121426 | 2.88 |
SNRNP27 |
small nuclear ribonucleoprotein 27kDa (U4/U6.U5) |
15 |
0.96 |
chr7_140179113_140179292 | 2.88 |
MKRN1 |
makorin ring finger protein 1 |
34 |
0.98 |
chr15_78592072_78592304 | 2.86 |
WDR61 |
WD repeat domain 61 |
52 |
0.96 |
chr11_77705711_77705938 | 2.85 |
INTS4 |
integrator complex subunit 4 |
100 |
0.95 |
chr19_53073539_53073842 | 2.85 |
ZNF701 |
zinc finger protein 701 |
136 |
0.92 |
chrX_154298671_154299361 | 2.84 |
MTCP1 |
mature T-cell proliferation 1 |
485 |
0.41 |
chr1_47780085_47780451 | 2.82 |
STIL |
SCL/TAL1 interrupting locus |
449 |
0.82 |
chr2_130986869_130987258 | 2.80 |
TUBA3E |
tubulin, alpha 3e |
31029 |
0.11 |
chr14_97925415_97925566 | 2.79 |
ENSG00000240730 |
. |
71020 |
0.14 |
chrX_134429796_134430051 | 2.79 |
ZNF75D |
zinc finger protein 75D |
36 |
0.98 |
chr2_201981306_201981819 | 2.79 |
CFLAR |
CASP8 and FADD-like apoptosis regulator |
2 |
0.97 |
chr2_32502679_32502951 | 2.77 |
YIPF4 |
Yip1 domain family, member 4 |
164 |
0.95 |
chr3_3214996_3215328 | 2.77 |
CRBN |
cereblon |
6196 |
0.2 |
chr20_32891259_32891430 | 2.76 |
AHCY |
adenosylhomocysteinase |
190 |
0.93 |
chr11_64814809_64815255 | 2.75 |
NAALADL1 |
N-acetylated alpha-linked acidic dipeptidase-like 1 |
301 |
0.74 |
chr2_106392629_106392859 | 2.75 |
NCK2 |
NCK adaptor protein 2 |
30556 |
0.23 |
chrX_74376165_74376390 | 2.75 |
ABCB7 |
ATP-binding cassette, sub-family B (MDR/TAP), member 7 |
145 |
0.97 |
chr6_139644906_139645379 | 2.73 |
TXLNB |
taxilin beta |
31866 |
0.17 |
chr17_3599450_3599734 | 2.73 |
P2RX5 |
purinergic receptor P2X, ligand-gated ion channel, 5 |
82 |
0.94 |
chr10_15902472_15902762 | 2.73 |
FAM188A |
family with sequence similarity 188, member A |
98 |
0.98 |
chr12_125424302_125424501 | 2.71 |
UBC |
ubiquitin C |
22487 |
0.14 |
chr4_122103316_122103738 | 2.69 |
ENSG00000252183 |
. |
10531 |
0.22 |
chr11_65479518_65479744 | 2.69 |
KAT5 |
K(lysine) acetyltransferase 5 |
79 |
0.94 |
chr1_2524059_2524476 | 2.69 |
MMEL1 |
membrane metallo-endopeptidase-like 1 |
150 |
0.92 |
chr17_80009726_80010013 | 2.68 |
GPS1 |
G protein pathway suppressor 1 |
35 |
0.71 |
chr11_65769730_65769998 | 2.67 |
BANF1 |
barrier to autointegration factor 1 |
137 |
0.59 |
chr14_105864635_105864945 | 2.67 |
TEX22 |
testis expressed 22 |
130 |
0.94 |
chr1_20511832_20511983 | 2.65 |
UBXN10 |
UBX domain protein 10 |
671 |
0.52 |
chr20_30311528_30311769 | 2.65 |
BCL2L1 |
BCL2-like 1 |
55 |
0.96 |
chr5_544016_544540 | 2.64 |
ENSG00000264233 |
. |
8281 |
0.14 |
chr16_14109259_14109410 | 2.63 |
MKL2 |
MKL/myocardin-like 2 |
55844 |
0.14 |
chr5_100239849_100240360 | 2.63 |
ST8SIA4 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
1134 |
0.65 |
chr10_44341794_44342095 | 2.62 |
ENSG00000238957 |
. |
188044 |
0.03 |
chr10_15001688_15002133 | 2.62 |
MEIG1 |
meiosis/spermiogenesis associated 1 |
472 |
0.8 |
chr20_2821581_2822008 | 2.62 |
PCED1A |
PC-esterase domain containing 1A |
42 |
0.85 |
chr2_136742312_136743099 | 2.61 |
AC093391.2 |
|
41 |
0.85 |
chr19_3971330_3971559 | 2.58 |
DAPK3 |
death-associated protein kinase 3 |
323 |
0.79 |
chr20_62673666_62674083 | 2.58 |
ZNF512B |
zinc finger protein 512B |
3936 |
0.11 |
chrY_1274756_1275442 | 2.58 |
NA |
NA |
> 106 |
NA |
chr1_26644479_26644742 | 2.56 |
UBXN11 |
UBX domain protein 11 |
146 |
0.51 |
chr4_41936970_41937430 | 2.56 |
TMEM33 |
transmembrane protein 33 |
31 |
0.98 |
chr3_38178855_38179307 | 2.56 |
ACAA1 |
acetyl-CoA acyltransferase 1 |
348 |
0.73 |
chr3_113252540_113252793 | 2.55 |
SIDT1 |
SID1 transmembrane family, member 1 |
1448 |
0.4 |
chr7_6865666_6865937 | 2.55 |
CCZ1B |
CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae) |
25 |
0.98 |
chr2_112940980_112941186 | 2.55 |
FBLN7 |
fibulin 7 |
1623 |
0.45 |
chr3_19988451_19988692 | 2.55 |
RAB5A |
RAB5A, member RAS oncogene family |
0 |
0.54 |
chr17_42264335_42264516 | 2.54 |
TMUB2 |
transmembrane and ubiquitin-like domain containing 2 |
7 |
0.82 |
chr2_75937833_75938047 | 2.53 |
GCFC2 |
GC-rich sequence DNA-binding factor 2 |
78 |
0.97 |
chr7_99006283_99006480 | 2.53 |
PDAP1 |
PDGFA associated protein 1 |
71 |
0.55 |
chr6_73972835_73973616 | 2.52 |
RP11-398K22.12 |
|
143 |
0.64 |
chr5_141404364_141404742 | 2.51 |
GNPDA1 |
glucosamine-6-phosphate deaminase 1 |
11947 |
0.17 |
chr1_21619720_21620176 | 2.51 |
RP5-1071N3.1 |
|
165 |
0.91 |
chr10_17657444_17657595 | 2.50 |
PTPLA |
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
1715 |
0.35 |
chr3_129118170_129118584 | 2.49 |
RPL32P3 |
ribosomal protein L32 pseudogene 3 |
129 |
0.94 |
chr12_68985651_68985802 | 2.48 |
RAP1B |
RAP1B, member of RAS oncogene family |
18893 |
0.21 |
chr6_26538344_26538636 | 2.48 |
HMGN4 |
high mobility group nucleosomal binding domain 4 |
143 |
0.95 |
chr2_241075331_241075797 | 2.48 |
MYEOV2 |
myeloma overexpressed 2 |
156 |
0.95 |
chr13_29232991_29233260 | 2.48 |
POMP |
proteasome maturation protein |
116 |
0.98 |
chr9_19102189_19102378 | 2.48 |
HAUS6 |
HAUS augmin-like complex, subunit 6 |
834 |
0.48 |
chr19_49839028_49839359 | 2.47 |
CD37 |
CD37 molecule |
472 |
0.63 |
chr2_48540846_48540997 | 2.47 |
FOXN2 |
forkhead box N2 |
855 |
0.67 |
chr15_59949896_59950061 | 2.47 |
GTF2A2 |
general transcription factor IIA, 2, 12kDa |
241 |
0.9 |
chr2_204732590_204732741 | 2.47 |
CTLA4 |
cytotoxic T-lymphocyte-associated protein 4 |
1 |
0.99 |
chr6_28104223_28104688 | 2.46 |
ZSCAN16-AS1 |
ZSCAN16 antisense RNA 1 |
189 |
0.91 |
chr2_25546155_25546306 | 2.46 |
ENSG00000221445 |
. |
5360 |
0.24 |
chr17_62008816_62009028 | 2.45 |
CD79B |
CD79b molecule, immunoglobulin-associated beta |
699 |
0.54 |
chr17_19015939_19016273 | 2.43 |
ENSG00000262202 |
. |
157 |
0.9 |
chr14_65381486_65381648 | 2.43 |
CHURC1-FNTB |
CHURC1-FNTB readthrough |
356 |
0.32 |
chr2_74518166_74518317 | 2.41 |
SLC4A5 |
solute carrier family 4 (sodium bicarbonate cotransporter), member 5 |
409 |
0.81 |
chr17_56565203_56565440 | 2.41 |
HSF5 |
heat shock transcription factor family member 5 |
424 |
0.77 |
chr3_50645256_50645407 | 2.40 |
CISH |
cytokine inducible SH2-containing protein |
3872 |
0.17 |
chr8_134511475_134511742 | 2.40 |
ST3GAL1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
4 |
0.99 |
chr4_159644501_159644814 | 2.40 |
PPID |
peptidylprolyl isomerase D |
109 |
0.96 |
chr12_104871725_104872091 | 2.38 |
CHST11 |
carbohydrate (chondroitin 4) sulfotransferase 11 |
21129 |
0.25 |
chrX_131614340_131615550 | 2.38 |
MBNL3 |
muscleblind-like splicing regulator 3 |
8098 |
0.3 |
chr13_75900993_75901212 | 2.38 |
TBC1D4 |
TBC1 domain family, member 4 |
14565 |
0.24 |
chrX_51139450_51139601 | 2.37 |
RP11-348F1.3 |
|
211 |
0.95 |
chr17_37844122_37844360 | 2.37 |
PGAP3 |
post-GPI attachment to proteins 3 |
69 |
0.49 |
chr11_118272295_118273229 | 2.37 |
RP11-770J1.5 |
Uncharacterized protein |
152 |
0.75 |
chr1_183604521_183604910 | 2.36 |
ARPC5 |
actin related protein 2/3 complex, subunit 5, 16kDa |
102 |
0.87 |
chr4_164480063_164480214 | 2.36 |
ENSG00000264535 |
. |
35694 |
0.17 |
chr12_6797826_6798167 | 2.35 |
ZNF384 |
zinc finger protein 384 |
29 |
0.94 |
chr1_203734376_203734572 | 2.35 |
LAX1 |
lymphocyte transmembrane adaptor 1 |
169 |
0.94 |
chr19_4916483_4916936 | 2.35 |
ARRDC5 |
arrestin domain containing 5 |
13830 |
0.12 |
chr7_64254828_64255323 | 2.34 |
ZNF138 |
zinc finger protein 138 |
269 |
0.94 |
chr6_31620204_31620418 | 2.34 |
BAG6 |
BCL2-associated athanogene 6 |
89 |
0.5 |
chr5_1633918_1634363 | 2.33 |
RP11-43F13.1 |
|
119 |
0.97 |
chr7_154795580_154795843 | 2.33 |
PAXIP1 |
PAX interacting (with transcription-activation domain) protein 1 |
917 |
0.58 |
chr1_154925638_154925789 | 2.33 |
PBXIP1 |
pre-B-cell leukemia homeobox interacting protein 1 |
2867 |
0.11 |
chr19_42052040_42052310 | 2.32 |
CEACAM21 |
carcinoembryonic antigen-related cell adhesion molecule 21 |
3711 |
0.2 |
chr16_30759296_30759478 | 2.31 |
PHKG2 |
phosphorylase kinase, gamma 2 (testis) |
204 |
0.86 |
chr10_16478967_16479383 | 2.31 |
PTER |
phosphotriesterase related |
192 |
0.95 |
chr4_38320716_38321108 | 2.31 |
ENSG00000221495 |
. |
80678 |
0.11 |
chr22_38023673_38023836 | 2.31 |
SH3BP1 |
SH3-domain binding protein 1 |
11728 |
0.1 |
chr1_42922209_42922953 | 2.31 |
PPCS |
phosphopantothenoylcysteine synthetase |
349 |
0.67 |
chr10_132099150_132099377 | 2.30 |
GLRX3 |
glutaredoxin 3 |
164600 |
0.04 |
chr5_140864812_140865036 | 2.30 |
PCDHGC4 |
protocadherin gamma subfamily C, 4 |
183 |
0.87 |
chr9_115819072_115819533 | 2.30 |
ZFP37 |
ZFP37 zinc finger protein |
263 |
0.94 |
chr5_133450980_133451278 | 2.29 |
TCF7 |
transcription factor 7 (T-cell specific, HMG-box) |
125 |
0.97 |
chr6_10694812_10695066 | 2.29 |
PAK1IP1 |
PAK1 interacting protein 1 |
11 |
0.57 |
chr2_118845469_118845991 | 2.29 |
INSIG2 |
insulin induced gene 2 |
320 |
0.91 |
chr12_54745959_54746186 | 2.28 |
RP11-753H16.3 |
|
1373 |
0.19 |
chr7_150329208_150329551 | 2.28 |
GIMAP6 |
GTPase, IMAP family member 6 |
55 |
0.98 |
chrX_106959148_106959639 | 2.28 |
TSC22D3 |
TSC22 domain family, member 3 |
238 |
0.95 |
chr8_21769513_21769765 | 2.28 |
DOK2 |
docking protein 2, 56kDa |
1535 |
0.4 |
chr3_16927344_16927610 | 2.28 |
PLCL2 |
phospholipase C-like 2 |
1025 |
0.65 |
chr16_88769179_88769564 | 2.28 |
RNF166 |
ring finger protein 166 |
654 |
0.43 |
chr4_22239606_22240002 | 2.28 |
ENSG00000238383 |
. |
111269 |
0.07 |
chr2_37827996_37828326 | 2.27 |
AC006369.2 |
|
882 |
0.69 |
chr11_46581907_46582403 | 2.27 |
AMBRA1 |
autophagy/beclin-1 regulator 1 |
30759 |
0.15 |
chrX_108975728_108976381 | 2.27 |
ACSL4 |
acyl-CoA synthetase long-chain family member 4 |
388 |
0.89 |
chr17_26988932_26989176 | 2.27 |
SUPT6H |
suppressor of Ty 6 homolog (S. cerevisiae) |
55 |
0.59 |
chr17_19093552_19093880 | 2.27 |
ENSG00000264940 |
. |
158 |
0.9 |
chr13_50698385_50698672 | 2.27 |
DLEU1 |
deleted in lymphocytic leukemia 1 (non-protein coding) |
42221 |
0.15 |
chr8_144717886_144718135 | 2.27 |
ZNF623 |
zinc finger protein 623 |
173 |
0.86 |
chr13_99195211_99195547 | 2.27 |
STK24 |
serine/threonine kinase 24 |
21127 |
0.2 |
chr7_155283292_155284101 | 2.26 |
AC008060.5 |
|
19282 |
0.17 |
chr10_43249759_43250194 | 2.26 |
BMS1 |
BMS1 ribosome biogenesis factor |
28273 |
0.19 |
chr3_11684266_11684417 | 2.26 |
VGLL4 |
vestigial like 4 (Drosophila) |
1057 |
0.58 |
chr12_49961755_49962069 | 2.26 |
MCRS1 |
microspherule protein 1 |
2 |
0.76 |
chr8_133772520_133773234 | 2.26 |
TMEM71 |
transmembrane protein 71 |
1 |
0.98 |
chr1_209943004_209943387 | 2.25 |
TRAF3IP3 |
TRAF3 interacting protein 3 |
1235 |
0.37 |
chr10_53458598_53459393 | 2.25 |
CSTF2T |
cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa, tau variant |
360 |
0.92 |
chr17_19091011_19091355 | 2.25 |
ENSG00000263934 |
. |
146 |
0.9 |
chr1_172412349_172413235 | 2.25 |
PIGC |
phosphatidylinositol glycan anchor biosynthesis, class C |
408 |
0.79 |
chr18_11908463_11908810 | 2.24 |
MPPE1 |
metallophosphoesterase 1 |
5 |
0.55 |
chr17_18964908_18965219 | 2.24 |
ENSG00000265185 |
. |
162 |
0.91 |
chr7_128694895_128695196 | 2.23 |
TNPO3 |
transportin 3 |
77 |
0.97 |
chr13_114894590_114895222 | 2.22 |
RASA3 |
RAS p21 protein activator 3 |
3121 |
0.29 |
chr4_83350861_83351264 | 2.22 |
HNRNPDL |
heterogeneous nuclear ribonucleoprotein D-like |
43 |
0.93 |
chr19_58095435_58095939 | 2.22 |
ZIK1 |
zinc finger protein interacting with K protein 1 |
59 |
0.94 |
chr1_76620087_76620697 | 2.22 |
ST6GALNAC3 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 |
79988 |
0.11 |
chr12_89792004_89792163 | 2.21 |
DUSP6 |
dual specificity phosphatase 6 |
45035 |
0.16 |
chr12_53715045_53715401 | 2.21 |
AAAS |
achalasia, adrenocortical insufficiency, alacrimia |
142 |
0.92 |
chr22_42177341_42177492 | 2.21 |
MEI1 |
meiosis inhibitor 1 |
323 |
0.83 |
chr22_45559923_45560225 | 2.21 |
NUP50 |
nucleoporin 50kDa |
193 |
0.94 |
chr10_134150291_134150926 | 2.20 |
LRRC27 |
leucine rich repeat containing 27 |
236 |
0.93 |
chr20_35362111_35362305 | 2.19 |
NDRG3 |
NDRG family member 3 |
12018 |
0.15 |
chr19_45393848_45394047 | 2.19 |
TOMM40 |
translocase of outer mitochondrial membrane 40 homolog (yeast) |
121 |
0.58 |
chr5_271405_271556 | 2.19 |
CTD-2083E4.6 |
|
151 |
0.64 |
chr22_50628950_50629632 | 2.19 |
TRABD |
TraB domain containing |
264 |
0.78 |
chrX_4158791_4158942 | 2.19 |
ENSG00000264861 |
. |
342675 |
0.01 |
chr5_14992829_14992980 | 2.18 |
ENSG00000212036 |
. |
82155 |
0.1 |
chr8_102120904_102121301 | 2.18 |
ENSG00000202360 |
. |
29085 |
0.21 |
chr4_15683336_15683962 | 2.18 |
FAM200B |
family with sequence similarity 200, member B |
220 |
0.69 |
chr16_81031171_81031400 | 2.17 |
CMC2 |
C-x(9)-C motif containing 2 |
979 |
0.45 |
chr17_4389769_4390006 | 2.17 |
RP13-580F15.2 |
|
239 |
0.89 |
chr3_39424819_39425031 | 2.17 |
SLC25A38 |
solute carrier family 25, member 38 |
45 |
0.97 |
chr21_36118027_36118375 | 2.17 |
AP000330.8 |
|
67 |
0.98 |
chr11_134094076_134094379 | 2.17 |
NCAPD3 |
non-SMC condensin II complex, subunit D3 |
199 |
0.63 |
chr3_146187244_146187543 | 2.17 |
PLSCR2 |
phospholipid scramblase 2 |
305 |
0.93 |
chr1_185663326_185663550 | 2.16 |
HMCN1 |
hemicentin 1 |
40245 |
0.17 |
chr8_19302898_19303049 | 2.16 |
SH2D4A |
SH2 domain containing 4A |
125872 |
0.06 |
chr16_31724624_31724825 | 2.16 |
ZNF720 |
zinc finger protein 720 |
97 |
0.95 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 10.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
2.2 | 2.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
2.0 | 8.0 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
1.7 | 6.7 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
1.6 | 7.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
1.5 | 4.6 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.5 | 4.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.5 | 5.9 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
1.5 | 5.9 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
1.4 | 1.4 | GO:0002360 | T cell lineage commitment(GO:0002360) |
1.4 | 2.8 | GO:0010761 | fibroblast migration(GO:0010761) |
1.4 | 4.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.4 | 5.6 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
1.3 | 3.8 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
1.3 | 1.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.2 | 1.2 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
1.2 | 4.9 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
1.2 | 3.6 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
1.2 | 4.7 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
1.2 | 9.3 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
1.1 | 5.7 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
1.1 | 5.7 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
1.1 | 2.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.1 | 3.3 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
1.1 | 3.3 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
1.1 | 5.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
1.1 | 2.1 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) membrane raft localization(GO:0051665) |
1.1 | 3.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
1.1 | 7.4 | GO:0070897 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
1.1 | 4.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.0 | 1.0 | GO:0045759 | negative regulation of action potential(GO:0045759) |
1.0 | 2.1 | GO:0070602 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
1.0 | 3.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.0 | 4.1 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
1.0 | 3.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
1.0 | 1.0 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
1.0 | 1.0 | GO:0002335 | mature B cell differentiation(GO:0002335) |
1.0 | 3.0 | GO:0010447 | response to acidic pH(GO:0010447) |
1.0 | 1.0 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) |
1.0 | 3.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
1.0 | 4.9 | GO:0070670 | response to interleukin-4(GO:0070670) |
1.0 | 6.9 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
1.0 | 2.0 | GO:0006154 | adenosine catabolic process(GO:0006154) |
1.0 | 2.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.0 | 1.9 | GO:0070672 | response to interleukin-15(GO:0070672) |
1.0 | 5.8 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
1.0 | 2.9 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
1.0 | 7.7 | GO:0007172 | signal complex assembly(GO:0007172) |
1.0 | 1.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
1.0 | 3.8 | GO:0022038 | corpus callosum development(GO:0022038) |
1.0 | 3.8 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.0 | 2.9 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
1.0 | 1.0 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.9 | 2.8 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.9 | 2.8 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.9 | 5.6 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.9 | 3.7 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.9 | 2.8 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.9 | 4.5 | GO:2001259 | positive regulation of calcium ion transmembrane transporter activity(GO:1901021) positive regulation of cation channel activity(GO:2001259) |
0.9 | 1.8 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.9 | 2.7 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.9 | 0.9 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.9 | 3.5 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.9 | 2.6 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.9 | 1.7 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.9 | 0.9 | GO:1903078 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.9 | 2.6 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.9 | 4.3 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.9 | 5.1 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.8 | 3.4 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.8 | 1.7 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.8 | 1.7 | GO:0002911 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.8 | 3.4 | GO:0051168 | nuclear export(GO:0051168) |
0.8 | 4.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.8 | 2.5 | GO:0016559 | peroxisome fission(GO:0016559) |
0.8 | 1.7 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.8 | 2.5 | GO:0051136 | NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.8 | 1.7 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.8 | 3.3 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.8 | 2.5 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.8 | 0.8 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.8 | 4.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.8 | 2.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.8 | 5.7 | GO:0015886 | heme transport(GO:0015886) |
0.8 | 2.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.8 | 3.2 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.8 | 5.7 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.8 | 2.4 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.8 | 0.8 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.8 | 2.4 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.8 | 0.8 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.8 | 2.4 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.8 | 1.6 | GO:0006198 | cAMP catabolic process(GO:0006198) cyclic nucleotide catabolic process(GO:0009214) |
0.8 | 1.6 | GO:0008049 | male courtship behavior(GO:0008049) |
0.8 | 5.5 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.8 | 0.8 | GO:0046635 | positive regulation of alpha-beta T cell activation(GO:0046635) |
0.8 | 0.8 | GO:0002507 | tolerance induction(GO:0002507) |
0.8 | 2.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.8 | 2.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.8 | 1.6 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.8 | 6.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.8 | 0.8 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.8 | 2.3 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.8 | 3.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.8 | 3.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.8 | 3.1 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.8 | 3.1 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.8 | 0.8 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.8 | 3.0 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.8 | 1.5 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.8 | 9.8 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.8 | 0.8 | GO:0046622 | positive regulation of organ growth(GO:0046622) |
0.7 | 2.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.7 | 1.5 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.7 | 3.0 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.7 | 3.7 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.7 | 2.9 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.7 | 3.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.7 | 2.2 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.7 | 2.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.7 | 2.2 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.7 | 4.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.7 | 2.2 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.7 | 4.4 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.7 | 2.2 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.7 | 5.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.7 | 2.2 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.7 | 1.4 | GO:0033622 | integrin activation(GO:0033622) |
0.7 | 3.6 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
0.7 | 2.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.7 | 0.7 | GO:0032661 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
0.7 | 1.4 | GO:0003032 | detection of oxygen(GO:0003032) |
0.7 | 2.1 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.7 | 1.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.7 | 2.8 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.7 | 1.4 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.7 | 3.5 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.7 | 2.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.7 | 2.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.7 | 0.7 | GO:0050951 | detection of temperature stimulus(GO:0016048) sensory perception of temperature stimulus(GO:0050951) detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.7 | 4.9 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.7 | 0.7 | GO:0070265 | necrotic cell death(GO:0070265) |
0.7 | 1.4 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.7 | 1.4 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.7 | 2.8 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.7 | 3.4 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.7 | 0.7 | GO:0048478 | replication fork protection(GO:0048478) |
0.7 | 17.8 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.7 | 6.1 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.7 | 1.4 | GO:0045047 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.7 | 1.3 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.7 | 2.0 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.7 | 2.0 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.7 | 1.3 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.7 | 5.3 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.7 | 1.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.7 | 2.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.7 | 1.3 | GO:0044415 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.7 | 3.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.7 | 4.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.7 | 7.9 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.7 | 2.0 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.7 | 2.6 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.7 | 5.2 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.7 | 0.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.7 | 13.1 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.7 | 4.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.6 | 0.6 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.6 | 1.3 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.6 | 2.6 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.6 | 1.9 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.6 | 7.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.6 | 1.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.6 | 5.8 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.6 | 1.9 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) regulation of lamellipodium organization(GO:1902743) |
0.6 | 1.9 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.6 | 0.6 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) negative regulation of metanephros development(GO:0072217) |
0.6 | 1.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.6 | 2.5 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.6 | 1.3 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) regulation of mesoderm development(GO:2000380) |
0.6 | 2.5 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.6 | 5.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.6 | 1.9 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.6 | 0.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.6 | 1.2 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.6 | 15.6 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.6 | 7.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.6 | 1.2 | GO:0032506 | cytokinetic process(GO:0032506) |
0.6 | 1.9 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.6 | 1.2 | GO:0032653 | regulation of interleukin-10 production(GO:0032653) |
0.6 | 3.7 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.6 | 3.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.6 | 1.2 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.6 | 1.2 | GO:0080111 | DNA demethylation(GO:0080111) |
0.6 | 3.0 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.6 | 1.8 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.6 | 3.0 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.6 | 2.4 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.6 | 6.0 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.6 | 4.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.6 | 2.4 | GO:0051322 | anaphase(GO:0051322) |
0.6 | 0.6 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.6 | 1.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.6 | 2.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.6 | 1.8 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.6 | 1.8 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.6 | 4.1 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.6 | 9.4 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.6 | 0.6 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.6 | 1.2 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.6 | 5.8 | GO:0070076 | histone lysine demethylation(GO:0070076) |
0.6 | 1.2 | GO:0009405 | pathogenesis(GO:0009405) |
0.6 | 4.7 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.6 | 1.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.6 | 0.6 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.6 | 0.6 | GO:0090382 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.6 | 4.0 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.6 | 4.6 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.6 | 3.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.6 | 1.7 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.6 | 0.6 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
0.6 | 3.4 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.6 | 9.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.6 | 2.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.6 | 1.7 | GO:0018343 | protein farnesylation(GO:0018343) |
0.6 | 11.8 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.6 | 2.2 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.6 | 1.1 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.6 | 2.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.6 | 3.9 | GO:0006266 | DNA ligation(GO:0006266) |
0.6 | 1.7 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.6 | 1.1 | GO:0051775 | response to redox state(GO:0051775) |
0.6 | 1.1 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.6 | 1.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.6 | 3.3 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.6 | 2.2 | GO:0070527 | platelet aggregation(GO:0070527) |
0.6 | 2.8 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.6 | 6.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.6 | 1.1 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.6 | 0.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.6 | 1.7 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.5 | 3.8 | GO:1902001 | carnitine shuttle(GO:0006853) intracellular lipid transport(GO:0032365) fatty acid transmembrane transport(GO:1902001) carnitine transmembrane transport(GO:1902603) |
0.5 | 1.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.5 | 8.8 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.5 | 1.6 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.5 | 1.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.5 | 1.6 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.5 | 8.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.5 | 2.2 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.5 | 0.5 | GO:2000050 | regulation of non-canonical Wnt signaling pathway(GO:2000050) |
0.5 | 0.5 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.5 | 1.6 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.5 | 6.0 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.5 | 1.6 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.5 | 6.5 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.5 | 1.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.5 | 0.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.5 | 1.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.5 | 10.1 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.5 | 1.6 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.5 | 2.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.5 | 3.2 | GO:0002063 | chondrocyte development(GO:0002063) |
0.5 | 3.2 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.5 | 0.5 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.5 | 0.5 | GO:0060197 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.5 | 3.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.5 | 1.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.5 | 0.5 | GO:0021516 | dorsal spinal cord development(GO:0021516) spinal cord association neuron differentiation(GO:0021527) |
0.5 | 3.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.5 | 1.0 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.5 | 1.6 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.5 | 0.5 | GO:0016577 | histone demethylation(GO:0016577) |
0.5 | 1.0 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.5 | 2.1 | GO:0045329 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.5 | 0.5 | GO:0006312 | mitotic recombination(GO:0006312) |
0.5 | 0.5 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.5 | 1.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.5 | 2.1 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.5 | 1.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.5 | 1.5 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.5 | 8.2 | GO:0007030 | Golgi organization(GO:0007030) |
0.5 | 3.1 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.5 | 20.9 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.5 | 0.5 | GO:0009220 | pyrimidine ribonucleotide biosynthetic process(GO:0009220) |
0.5 | 0.5 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
0.5 | 3.0 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.5 | 6.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.5 | 1.0 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.5 | 0.5 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
0.5 | 1.0 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.5 | 0.5 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.5 | 3.0 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.5 | 0.5 | GO:0071028 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.5 | 0.5 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.5 | 2.5 | GO:0043928 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.5 | 6.0 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.5 | 0.5 | GO:0006828 | manganese ion transport(GO:0006828) |
0.5 | 1.5 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.5 | 2.0 | GO:0021610 | cranial nerve structural organization(GO:0021604) facial nerve morphogenesis(GO:0021610) facial nerve structural organization(GO:0021612) anatomical structure arrangement(GO:0048532) |
0.5 | 1.0 | GO:0033087 | regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.5 | 3.4 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.5 | 1.5 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.5 | 1.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.5 | 0.5 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.5 | 0.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.5 | 0.5 | GO:1904019 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.5 | 1.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.5 | 2.4 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.5 | 0.5 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.5 | 2.4 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.5 | 1.4 | GO:0033345 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.5 | 2.4 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.5 | 4.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.5 | 0.5 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.5 | 0.5 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.5 | 7.1 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.5 | 1.4 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.5 | 0.9 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.5 | 3.3 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.5 | 0.5 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.5 | 1.4 | GO:1903051 | negative regulation of proteolysis involved in cellular protein catabolic process(GO:1903051) |
0.5 | 1.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.5 | 0.9 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.5 | 0.9 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.5 | 1.4 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.5 | 1.4 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
0.5 | 1.4 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.5 | 1.4 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.5 | 0.5 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.5 | 4.6 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.5 | 1.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.5 | 2.8 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.5 | 1.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.5 | 1.4 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.5 | 2.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.5 | 0.9 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.5 | 0.9 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.5 | 9.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.5 | 2.7 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.5 | 2.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.5 | 6.4 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.5 | 0.5 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.5 | 1.8 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.5 | 0.9 | GO:0006862 | nucleotide transport(GO:0006862) |
0.5 | 1.4 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.5 | 2.3 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.5 | 2.7 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.5 | 5.0 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.5 | 3.6 | GO:0035964 | vesicle coating(GO:0006901) COPI-coated vesicle budding(GO:0035964) Golgi vesicle budding(GO:0048194) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) single-organism membrane budding(GO:1902591) |
0.5 | 1.4 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.5 | 0.9 | GO:0002420 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.5 | 5.4 | GO:0007031 | peroxisome organization(GO:0007031) |
0.5 | 0.9 | GO:0032845 | negative regulation of homeostatic process(GO:0032845) |
0.5 | 3.6 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.4 | 0.9 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.4 | 0.4 | GO:0001881 | receptor recycling(GO:0001881) |
0.4 | 44.8 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.4 | 1.3 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.4 | 2.2 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.4 | 0.9 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.4 | 0.4 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.4 | 0.9 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.4 | 1.3 | GO:0001510 | RNA methylation(GO:0001510) |
0.4 | 0.9 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.4 | 3.6 | GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) |
0.4 | 0.9 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.4 | 4.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.4 | 0.4 | GO:0061371 | heart looping(GO:0001947) embryonic heart tube morphogenesis(GO:0003143) determination of heart left/right asymmetry(GO:0061371) |
0.4 | 10.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.4 | 2.2 | GO:0009855 | determination of left/right symmetry(GO:0007368) determination of bilateral symmetry(GO:0009855) |
0.4 | 20.6 | GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition(GO:0051437) |
0.4 | 1.3 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.4 | 0.9 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.4 | 7.0 | GO:0016236 | macroautophagy(GO:0016236) |
0.4 | 1.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.4 | 1.7 | GO:0006983 | ER overload response(GO:0006983) |
0.4 | 0.4 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.4 | 7.4 | GO:0061641 | DNA replication-independent nucleosome assembly(GO:0006336) CENP-A containing nucleosome assembly(GO:0034080) DNA replication-independent nucleosome organization(GO:0034724) CENP-A containing chromatin organization(GO:0061641) |
0.4 | 0.4 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.4 | 2.6 | GO:1903311 | regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
0.4 | 0.4 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.4 | 5.2 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.4 | 13.8 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.4 | 2.6 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.4 | 0.9 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.4 | 8.2 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.4 | 28.4 | GO:0006415 | translational termination(GO:0006415) |
0.4 | 1.7 | GO:0051642 | centrosome localization(GO:0051642) |
0.4 | 8.2 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.4 | 5.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.4 | 0.9 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.4 | 0.9 | GO:0071357 | response to type I interferon(GO:0034340) type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.4 | 0.9 | GO:0032200 | telomere organization(GO:0032200) |
0.4 | 0.9 | GO:0042026 | protein refolding(GO:0042026) |
0.4 | 1.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.4 | 0.8 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.4 | 2.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.4 | 1.3 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.4 | 3.0 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.4 | 1.3 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.4 | 1.3 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.4 | 0.8 | GO:0015809 | arginine transport(GO:0015809) |
0.4 | 1.3 | GO:0045056 | transcytosis(GO:0045056) |
0.4 | 5.5 | GO:0042255 | ribosome assembly(GO:0042255) |
0.4 | 1.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.4 | 38.6 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.4 | 0.8 | GO:0060968 | regulation of gene silencing(GO:0060968) |
0.4 | 0.4 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.4 | 2.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.4 | 0.8 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.4 | 1.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.4 | 1.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.4 | 1.2 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.4 | 0.4 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.4 | 26.1 | GO:0051028 | mRNA transport(GO:0051028) |
0.4 | 1.2 | GO:0097205 | regulation of glomerular filtration(GO:0003093) glomerular filtration(GO:0003094) renal filtration(GO:0097205) regulation of renal system process(GO:0098801) |
0.4 | 1.6 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.4 | 6.1 | GO:0051225 | spindle assembly(GO:0051225) |
0.4 | 1.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.4 | 3.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.4 | 0.8 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.4 | 1.2 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.4 | 7.3 | GO:0006400 | tRNA modification(GO:0006400) |
0.4 | 2.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.4 | 11.6 | GO:0006397 | mRNA processing(GO:0006397) |
0.4 | 2.8 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.4 | 0.4 | GO:0032212 | regulation of telomere maintenance via telomerase(GO:0032210) positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.4 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.4 | 6.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.4 | 2.0 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.4 | 1.2 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.4 | 1.2 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.4 | 0.4 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.4 | 0.8 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.4 | 1.2 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.4 | 1.2 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.4 | 80.8 | GO:0016568 | chromatin modification(GO:0016568) |
0.4 | 0.4 | GO:0033483 | gas homeostasis(GO:0033483) |
0.4 | 0.8 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) regulation of membrane lipid distribution(GO:0097035) |
0.4 | 2.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.4 | 1.6 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.4 | 1.2 | GO:0071674 | mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.4 | 1.2 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.4 | 2.7 | GO:0007141 | male meiosis I(GO:0007141) |
0.4 | 1.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.4 | 0.8 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.4 | 1.5 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.4 | 2.3 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.4 | 0.4 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.4 | 0.4 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.4 | 1.2 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.4 | 0.4 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.4 | 0.4 | GO:0050706 | regulation of interleukin-1 beta secretion(GO:0050706) |
0.4 | 2.7 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.4 | 0.4 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.4 | 0.8 | GO:0007000 | nucleolus organization(GO:0007000) |
0.4 | 0.4 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.4 | 0.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.4 | 2.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.4 | 6.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.4 | 0.4 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.4 | 3.0 | GO:0022613 | ribonucleoprotein complex biogenesis(GO:0022613) |
0.4 | 0.8 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.4 | 28.6 | GO:0008380 | RNA splicing(GO:0008380) |
0.4 | 2.2 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
0.4 | 0.7 | GO:0071436 | sodium ion export(GO:0071436) |
0.4 | 1.5 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.4 | 0.4 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.4 | 0.4 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.4 | 3.0 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.4 | 3.3 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.4 | 3.7 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.4 | 15.9 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.4 | 0.7 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
0.4 | 0.7 | GO:0048069 | eye pigmentation(GO:0048069) |
0.4 | 4.4 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.4 | 6.6 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.4 | 4.8 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.4 | 0.7 | GO:0035246 | peptidyl-arginine methylation(GO:0018216) peptidyl-arginine N-methylation(GO:0035246) |
0.4 | 3.7 | GO:0030903 | notochord development(GO:0030903) |
0.4 | 2.2 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.4 | 2.2 | GO:0031529 | ruffle organization(GO:0031529) |
0.4 | 0.7 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.4 | 1.4 | GO:0000012 | single strand break repair(GO:0000012) |
0.4 | 1.4 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.4 | 1.1 | GO:0001821 | histamine secretion(GO:0001821) |
0.4 | 2.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.4 | 0.4 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.4 | 2.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.4 | 1.1 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.4 | 0.7 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.4 | 0.7 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.4 | 0.7 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.4 | 5.6 | GO:0036503 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
0.4 | 6.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.4 | 1.8 | GO:0002467 | germinal center formation(GO:0002467) |
0.3 | 0.7 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.3 | 0.7 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.3 | 0.3 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.3 | 0.3 | GO:0009612 | response to mechanical stimulus(GO:0009612) |
0.3 | 33.0 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.3 | 0.7 | GO:0048599 | oocyte development(GO:0048599) |
0.3 | 1.4 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.3 | 8.3 | GO:0034134 | toll-like receptor 1 signaling pathway(GO:0034130) toll-like receptor 2 signaling pathway(GO:0034134) |
0.3 | 1.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.3 | 1.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.3 | 2.8 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.3 | 1.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.3 | 0.3 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.3 | 0.3 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.3 | 5.1 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.3 | 2.4 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.3 | 2.0 | GO:0006896 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.3 | 0.7 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.3 | 4.8 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.3 | 0.3 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.3 | 1.4 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.3 | 1.0 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.3 | 1.7 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
0.3 | 1.3 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.3 | 3.7 | GO:0051320 | S phase(GO:0051320) |
0.3 | 0.7 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.3 | 1.0 | GO:0043487 | regulation of RNA stability(GO:0043487) |
0.3 | 1.3 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.3 | 0.3 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.3 | 16.7 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.3 | 0.3 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.3 | 0.3 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.3 | 0.3 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.3 | 39.1 | GO:0016032 | viral process(GO:0016032) |
0.3 | 7.6 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.3 | 10.2 | GO:0006366 | transcription from RNA polymerase II promoter(GO:0006366) |
0.3 | 3.0 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.3 | 0.7 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
0.3 | 7.9 | GO:0006302 | double-strand break repair(GO:0006302) |
0.3 | 0.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.3 | 4.6 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.3 | 4.2 | GO:0033045 | regulation of sister chromatid segregation(GO:0033045) |
0.3 | 1.0 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.3 | 40.3 | GO:0006457 | protein folding(GO:0006457) |
0.3 | 3.2 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.3 | 3.6 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.3 | 4.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 1.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.3 | 6.8 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.3 | 1.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 13.2 | GO:0008033 | tRNA processing(GO:0008033) |
0.3 | 1.6 | GO:0051904 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
0.3 | 2.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.3 | 0.3 | GO:0021754 | facial nucleus development(GO:0021754) |
0.3 | 0.3 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.3 | 1.9 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 1.6 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.3 | 4.8 | GO:0006414 | translational elongation(GO:0006414) |
0.3 | 2.2 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.3 | 0.6 | GO:1903322 | positive regulation of protein modification by small protein conjugation or removal(GO:1903322) |
0.3 | 1.3 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.3 | 0.6 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 7.9 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.3 | 11.3 | GO:0006413 | translational initiation(GO:0006413) |
0.3 | 0.3 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.3 | 0.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.3 | 0.6 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.3 | 0.9 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.3 | 1.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.3 | 17.7 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.3 | 1.2 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.3 | 0.6 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.3 | 8.6 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.3 | 8.6 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.3 | 2.5 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.3 | 0.9 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.3 | 0.3 | GO:0032606 | type I interferon production(GO:0032606) |
0.3 | 0.3 | GO:0048799 | ossification involved in bone maturation(GO:0043931) organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.3 | 2.4 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.3 | 0.6 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.3 | 4.5 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.3 | 2.4 | GO:0030261 | chromosome condensation(GO:0030261) |
0.3 | 1.5 | GO:0033363 | secretory granule organization(GO:0033363) |
0.3 | 5.0 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.3 | 3.6 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.3 | 0.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.3 | 0.9 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.3 | 10.0 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.3 | 0.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.3 | 0.6 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.3 | 0.6 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.3 | 0.6 | GO:0001832 | blastocyst growth(GO:0001832) |
0.3 | 1.2 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.3 | 35.4 | GO:0043632 | modification-dependent macromolecule catabolic process(GO:0043632) |
0.3 | 1.7 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.3 | 0.3 | GO:0042504 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.3 | 0.3 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.3 | 2.0 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 2.9 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.3 | 1.4 | GO:0006903 | vesicle targeting(GO:0006903) |
0.3 | 0.3 | GO:0002329 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.3 | 1.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 0.6 | GO:0001935 | endothelial cell proliferation(GO:0001935) |
0.3 | 0.6 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 1.1 | GO:0072666 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.3 | 1.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.3 | 1.1 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.3 | 0.6 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.3 | 3.3 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.3 | 1.7 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.3 | 8.3 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
0.3 | 0.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.3 | 1.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.3 | 0.3 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.3 | 0.3 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.3 | 1.1 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
0.3 | 15.9 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.3 | 0.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.3 | 0.5 | GO:1900087 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.3 | 0.8 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.3 | 0.3 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.3 | 4.0 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.3 | 6.1 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.3 | 2.1 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.3 | 1.3 | GO:0034765 | regulation of ion transmembrane transport(GO:0034765) |
0.3 | 0.3 | GO:0001302 | replicative cell aging(GO:0001302) |
0.3 | 0.3 | GO:0007494 | midgut development(GO:0007494) |
0.3 | 43.2 | GO:0006412 | translation(GO:0006412) |
0.3 | 1.0 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.3 | 0.3 | GO:0001743 | optic placode formation(GO:0001743) |
0.3 | 0.5 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.3 | 6.0 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.3 | 1.6 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.3 | 3.1 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.3 | 0.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.3 | 2.1 | GO:0007032 | endosome organization(GO:0007032) |
0.3 | 1.3 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.3 | 2.6 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.3 | 1.8 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.3 | 0.5 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.3 | 0.8 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.3 | 0.8 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.3 | 0.3 | GO:0032880 | regulation of protein localization(GO:0032880) |
0.3 | 1.0 | GO:0006310 | DNA recombination(GO:0006310) |
0.2 | 7.5 | GO:0009185 | ribonucleoside diphosphate metabolic process(GO:0009185) |
0.2 | 1.5 | GO:0009268 | response to pH(GO:0009268) |
0.2 | 1.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 2.0 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 0.5 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 3.0 | GO:0097193 | intrinsic apoptotic signaling pathway(GO:0097193) |
0.2 | 0.5 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.2 | 0.2 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.2 | 0.5 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.2 | 1.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.2 | 0.5 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.2 | 0.2 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.2 | 1.9 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 1.0 | GO:0010458 | exit from mitosis(GO:0010458) |
0.2 | 1.0 | GO:0048241 | epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
0.2 | 0.2 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
0.2 | 3.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.2 | 0.7 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 0.2 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.2 | 0.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 0.2 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.2 | 0.2 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.2 | 0.2 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.2 | 0.9 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 4.0 | GO:0051169 | nuclear transport(GO:0051169) |
0.2 | 0.7 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.2 | 0.5 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.9 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.2 | 1.1 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 9.4 | GO:0007034 | vacuolar transport(GO:0007034) |
0.2 | 3.0 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.2 | 0.5 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.2 | 0.5 | GO:0051299 | centrosome separation(GO:0051299) |
0.2 | 0.7 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.2 | 0.2 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.2 | 0.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 0.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.2 | 0.2 | GO:0021587 | cerebellum morphogenesis(GO:0021587) |
0.2 | 0.2 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.2 | 0.2 | GO:0034331 | cell junction maintenance(GO:0034331) cellular component maintenance(GO:0043954) cell-cell junction maintenance(GO:0045217) |
0.2 | 0.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 0.7 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.2 | 4.6 | GO:0072655 | protein targeting to mitochondrion(GO:0006626) establishment of protein localization to mitochondrion(GO:0072655) |
0.2 | 0.9 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 0.9 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.2 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.2 | 1.5 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.2 | 0.7 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.2 | 20.4 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.2 | 0.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.2 | 2.2 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.2 | 1.3 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.2 | 0.2 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 0.9 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 0.4 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.2 | 0.6 | GO:0030238 | male sex determination(GO:0030238) |
0.2 | 1.3 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.2 | 0.2 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.2 | 1.3 | GO:0046689 | response to mercury ion(GO:0046689) |
0.2 | 0.4 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.2 | 0.4 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.2 | 0.2 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.2 | 1.9 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.2 | 0.2 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.2 | 0.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.4 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.2 | 0.4 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 10.5 | GO:0097190 | apoptotic signaling pathway(GO:0097190) |
0.2 | 0.2 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.2 | 2.6 | GO:0034032 | nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
0.2 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.2 | 0.2 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.2 | 0.8 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 0.2 | GO:0033198 | response to ATP(GO:0033198) |
0.2 | 0.6 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.2 | 0.4 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) dopamine catabolic process(GO:0042420) catecholamine catabolic process(GO:0042424) |
0.2 | 1.6 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.2 | 1.4 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.2 | 0.2 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.2 | 0.4 | GO:1990778 | protein localization to plasma membrane(GO:0072659) protein localization to cell periphery(GO:1990778) |
0.2 | 1.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 3.6 | GO:0007632 | visual behavior(GO:0007632) |
0.2 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.8 | GO:0061008 | liver development(GO:0001889) hepaticobiliary system development(GO:0061008) |
0.2 | 1.0 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 1.0 | GO:0045730 | respiratory burst(GO:0045730) |
0.2 | 0.2 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
0.2 | 0.2 | GO:0071156 | regulation of cell cycle arrest(GO:0071156) |
0.2 | 0.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 0.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.8 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 0.2 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.2 | 1.5 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 0.6 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.2 | 0.2 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.2 | 0.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.2 | 0.7 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.2 | 2.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.2 | 0.2 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.2 | 0.2 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.2 | 0.7 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 0.7 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.2 | 3.1 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.2 | 2.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 0.4 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 0.4 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.2 | 0.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.7 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.2 | 0.2 | GO:0030878 | thyroid gland development(GO:0030878) |
0.2 | 0.2 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.2 | 0.2 | GO:0046325 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
0.2 | 1.6 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.2 | 2.3 | GO:0007051 | spindle organization(GO:0007051) |
0.2 | 0.3 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.2 | 0.7 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 13.5 | GO:0006281 | DNA repair(GO:0006281) |
0.2 | 4.0 | GO:0006396 | RNA processing(GO:0006396) |
0.2 | 0.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 0.5 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.2 | 0.9 | GO:0044724 | single-organism carbohydrate catabolic process(GO:0044724) |
0.2 | 0.3 | GO:0046618 | drug export(GO:0046618) |
0.2 | 1.9 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.2 | 0.3 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.2 | 2.2 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.2 | 0.5 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.2 | 1.0 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.2 | 0.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.3 | GO:0051053 | negative regulation of DNA metabolic process(GO:0051053) |
0.2 | 12.8 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.2 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 1.5 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.2 | 0.8 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.6 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.2 | 1.4 | GO:0007005 | mitochondrion organization(GO:0007005) |
0.2 | 0.3 | GO:0021772 | olfactory bulb development(GO:0021772) olfactory lobe development(GO:0021988) |
0.2 | 9.3 | GO:0006486 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) glycosylation(GO:0070085) |
0.2 | 0.3 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.2 | 1.4 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.2 | 0.3 | GO:0002790 | peptide secretion(GO:0002790) |
0.2 | 2.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 5.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 1.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 0.6 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.2 | 0.5 | GO:1901215 | negative regulation of neuron apoptotic process(GO:0043524) negative regulation of neuron death(GO:1901215) |
0.2 | 0.2 | GO:0006997 | nucleus organization(GO:0006997) |
0.2 | 0.3 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
0.2 | 3.6 | GO:0019395 | fatty acid oxidation(GO:0019395) lipid oxidation(GO:0034440) |
0.2 | 0.3 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.2 | 0.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.5 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 0.2 | GO:0071503 | response to heparin(GO:0071503) |
0.1 | 1.2 | GO:0006949 | syncytium formation(GO:0006949) |
0.1 | 0.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.7 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.4 | GO:0006818 | hydrogen transport(GO:0006818) |
0.1 | 0.1 | GO:0032908 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 2.9 | GO:0006914 | autophagy(GO:0006914) |
0.1 | 1.3 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.7 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.1 | 0.4 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 4.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.1 | GO:0021683 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.6 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.6 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 2.2 | GO:0044839 | G2/M transition of mitotic cell cycle(GO:0000086) cell cycle G2/M phase transition(GO:0044839) |
0.1 | 0.3 | GO:0051318 | G1 phase(GO:0051318) |
0.1 | 0.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.1 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 1.1 | GO:0000910 | cytokinesis(GO:0000910) |
0.1 | 0.3 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.1 | 10.0 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.1 | 0.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.4 | GO:0045682 | regulation of epidermis development(GO:0045682) |
0.1 | 0.9 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.1 | 0.5 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.6 | GO:0009408 | response to heat(GO:0009408) |
0.1 | 0.1 | GO:1903307 | positive regulation of regulated secretory pathway(GO:1903307) |
0.1 | 0.3 | GO:0097306 | cellular response to alcohol(GO:0097306) |
0.1 | 0.8 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.5 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.1 | 0.6 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.1 | 2.0 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.1 | 0.6 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.1 | 0.6 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.4 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.5 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.1 | 0.2 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.9 | GO:0019627 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) nitrogen cycle metabolic process(GO:0071941) |
0.1 | 1.1 | GO:0006974 | cellular response to DNA damage stimulus(GO:0006974) |
0.1 | 0.2 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.4 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.1 | 0.2 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 0.4 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.5 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 0.1 | GO:0007045 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.1 | 0.3 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 0.2 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.1 | 1.8 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 0.2 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.1 | 0.2 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.1 | 2.5 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.1 | 1.4 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 2.4 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 1.1 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.1 | 0.6 | GO:0042891 | antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.1 | 0.5 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 9.1 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.1 | 3.7 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) purine nucleoside triphosphate biosynthetic process(GO:0009145) |
0.1 | 0.1 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.1 | 1.2 | GO:0043623 | cellular protein complex assembly(GO:0043623) |
0.1 | 0.5 | GO:0001504 | neurotransmitter uptake(GO:0001504) import into cell(GO:0098657) |
0.1 | 0.1 | GO:0043543 | protein acylation(GO:0043543) |
0.1 | 0.5 | GO:0000279 | M phase(GO:0000279) |
0.1 | 0.2 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate pattern specification(GO:0060896) neural plate regionalization(GO:0060897) |
0.1 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.3 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 0.1 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.1 | 0.2 | GO:0046034 | ATP metabolic process(GO:0046034) |
0.1 | 1.2 | GO:0030163 | protein catabolic process(GO:0030163) |
0.1 | 0.2 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.3 | GO:1900076 | regulation of insulin receptor signaling pathway(GO:0046626) regulation of cellular response to insulin stimulus(GO:1900076) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.2 | GO:0030318 | melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
0.1 | 0.4 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.3 | GO:0015722 | canalicular bile acid transport(GO:0015722) bile acid secretion(GO:0032782) |
0.1 | 1.4 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 1.7 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.1 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 11.4 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 0.9 | GO:1990266 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.1 | 0.1 | GO:0034123 | positive regulation of toll-like receptor signaling pathway(GO:0034123) |
0.1 | 1.6 | GO:0001906 | cell killing(GO:0001906) |
0.1 | 1.4 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 0.1 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.1 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.3 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.3 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.1 | 0.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.1 | GO:0050702 | interleukin-1 beta secretion(GO:0050702) |
0.1 | 0.8 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.5 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.1 | GO:0040029 | regulation of gene expression, epigenetic(GO:0040029) |
0.1 | 0.4 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.4 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.1 | 0.2 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.1 | 0.1 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.1 | 0.3 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 3.9 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.1 | 0.1 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.1 | 0.7 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.1 | 0.3 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.1 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.1 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.2 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.1 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.8 | GO:0042311 | vasodilation(GO:0042311) |
0.1 | 6.5 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.1 | 3.0 | GO:0042981 | regulation of apoptotic process(GO:0042981) |
0.1 | 0.2 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.1 | 0.2 | GO:0008216 | spermidine metabolic process(GO:0008216) spermidine biosynthetic process(GO:0008295) |
0.1 | 1.2 | GO:0007568 | aging(GO:0007568) |
0.1 | 0.5 | GO:0097202 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) activation of cysteine-type endopeptidase activity(GO:0097202) |
0.1 | 0.6 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.4 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.1 | 0.8 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.1 | 0.5 | GO:0090317 | negative regulation of intracellular protein transport(GO:0090317) |
0.1 | 0.3 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 0.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 4.3 | GO:0043066 | negative regulation of apoptotic process(GO:0043066) |
0.1 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.5 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.1 | 0.3 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.1 | GO:0043467 | regulation of generation of precursor metabolites and energy(GO:0043467) |
0.1 | 0.2 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.1 | 1.6 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.1 | 1.5 | GO:0006909 | phagocytosis(GO:0006909) |
0.1 | 0.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.2 | GO:0021761 | limbic system development(GO:0021761) |
0.1 | 0.1 | GO:0007259 | JAK-STAT cascade(GO:0007259) STAT cascade(GO:0097696) |
0.1 | 0.1 | GO:0003281 | ventricular septum development(GO:0003281) |
0.1 | 4.7 | GO:0006869 | lipid transport(GO:0006869) |
0.1 | 0.1 | GO:0010906 | regulation of glucose metabolic process(GO:0010906) |
0.1 | 2.5 | GO:0009615 | response to virus(GO:0009615) |
0.1 | 0.6 | GO:0051348 | negative regulation of transferase activity(GO:0051348) |
0.1 | 2.6 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.1 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.1 | 0.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) negative regulation of lipase activity(GO:0060192) |
0.1 | 8.2 | GO:0006915 | apoptotic process(GO:0006915) |
0.1 | 0.1 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 0.6 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.1 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) |
0.1 | 0.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) dendritic cell differentiation(GO:0097028) |
0.1 | 0.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 1.4 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.1 | 0.5 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.1 | 1.4 | GO:0010038 | response to metal ion(GO:0010038) |
0.1 | 0.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.2 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.2 | GO:0014904 | myotube cell development(GO:0014904) skeletal muscle fiber development(GO:0048741) |
0.1 | 0.5 | GO:0019915 | lipid storage(GO:0019915) |
0.1 | 0.3 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.1 | 2.2 | GO:0008219 | cell death(GO:0008219) |
0.1 | 0.2 | GO:0051238 | sequestering of metal ion(GO:0051238) |
0.1 | 0.5 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.1 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.1 | 64.4 | GO:1903506 | regulation of transcription, DNA-templated(GO:0006355) regulation of nucleic acid-templated transcription(GO:1903506) |
0.1 | 14.2 | GO:0015031 | protein transport(GO:0015031) |
0.1 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.6 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.1 | 0.7 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.1 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.1 | GO:0015851 | nucleobase transport(GO:0015851) |
0.0 | 0.1 | GO:0007346 | regulation of mitotic cell cycle(GO:0007346) |
0.0 | 0.0 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.4 | GO:0008154 | actin polymerization or depolymerization(GO:0008154) |
0.0 | 0.0 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.0 | 0.0 | GO:0015748 | organophosphate ester transport(GO:0015748) |
0.0 | 0.0 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.0 | 0.3 | GO:0043254 | regulation of protein complex assembly(GO:0043254) |
0.0 | 0.4 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.0 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.0 | 0.4 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.1 | GO:0042745 | circadian sleep/wake cycle process(GO:0022410) circadian sleep/wake cycle(GO:0042745) circadian sleep/wake cycle, sleep(GO:0050802) |
0.0 | 0.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.0 | 0.0 | GO:0072171 | mesonephric tubule morphogenesis(GO:0072171) |
0.0 | 0.0 | GO:0006325 | chromatin organization(GO:0006325) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.2 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.0 | GO:0010934 | macrophage cytokine production(GO:0010934) regulation of macrophage cytokine production(GO:0010935) |
0.0 | 0.6 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.0 | 0.0 | GO:0043114 | regulation of vascular permeability(GO:0043114) |
0.0 | 3.3 | GO:0007283 | spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
0.0 | 0.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.3 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) |
0.0 | 0.0 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
0.0 | 0.1 | GO:0016458 | gene silencing(GO:0016458) |
0.0 | 0.0 | GO:0051767 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) |
0.0 | 0.4 | GO:0044036 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.8 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.0 | 0.0 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.0 | 0.0 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.1 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.0 | 0.4 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.5 | GO:0016064 | immunoglobulin mediated immune response(GO:0016064) |
0.0 | 0.1 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.1 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.0 | 0.2 | GO:0046661 | male sex differentiation(GO:0046661) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.0 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.0 | 0.8 | GO:0006887 | exocytosis(GO:0006887) |
0.0 | 2.3 | GO:0007049 | cell cycle(GO:0007049) |
0.0 | 0.1 | GO:0051276 | chromosome organization(GO:0051276) |
0.0 | 0.3 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.1 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.0 | GO:0098727 | stem cell population maintenance(GO:0019827) maintenance of cell number(GO:0098727) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.1 | GO:0005977 | glycogen metabolic process(GO:0005977) |
0.0 | 0.0 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.0 | GO:0042752 | regulation of circadian rhythm(GO:0042752) |
0.0 | 0.0 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.0 | 0.0 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.8 | GO:0016070 | RNA metabolic process(GO:0016070) |
0.0 | 0.0 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.0 | 0.0 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.0 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.0 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
0.0 | 0.0 | GO:0097006 | plasma lipoprotein particle organization(GO:0071827) regulation of plasma lipoprotein particle levels(GO:0097006) |
0.0 | 0.0 | GO:0042593 | carbohydrate homeostasis(GO:0033500) glucose homeostasis(GO:0042593) |
0.0 | 0.1 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.1 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.1 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.0 | 0.0 | GO:0009755 | hormone-mediated signaling pathway(GO:0009755) |
0.0 | 4.3 | GO:0007608 | sensory perception of smell(GO:0007608) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 13.9 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.6 | 4.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.5 | 4.6 | GO:0072487 | MSL complex(GO:0072487) |
1.5 | 5.9 | GO:0005827 | polar microtubule(GO:0005827) |
1.3 | 5.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
1.3 | 3.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.2 | 4.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
1.2 | 3.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.1 | 3.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
1.1 | 3.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.0 | 7.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
1.0 | 3.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.0 | 3.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
1.0 | 5.9 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
1.0 | 2.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
1.0 | 5.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.9 | 16.0 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.9 | 2.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.9 | 3.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.9 | 6.9 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.8 | 10.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.8 | 3.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.8 | 3.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.8 | 0.8 | GO:0005694 | chromosome(GO:0005694) |
0.8 | 2.5 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.8 | 4.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.8 | 4.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.8 | 3.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.8 | 4.0 | GO:0005682 | U5 snRNP(GO:0005682) |
0.8 | 9.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.8 | 11.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.8 | 3.8 | GO:0000796 | condensin complex(GO:0000796) |
0.8 | 3.0 | GO:0042825 | TAP complex(GO:0042825) |
0.8 | 7.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.7 | 5.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.7 | 3.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.7 | 2.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.7 | 2.8 | GO:0000791 | euchromatin(GO:0000791) |
0.7 | 3.5 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.7 | 2.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.7 | 8.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.7 | 5.5 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.7 | 6.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.7 | 0.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.7 | 2.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.7 | 4.0 | GO:0042382 | paraspeckles(GO:0042382) |
0.7 | 2.0 | GO:0016604 | nuclear body(GO:0016604) |
0.7 | 1.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.7 | 2.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.7 | 6.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.6 | 8.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.6 | 9.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.6 | 5.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.6 | 6.3 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.6 | 0.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.6 | 1.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.6 | 4.9 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.6 | 2.4 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.6 | 2.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.6 | 2.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.6 | 1.8 | GO:0034464 | BBSome(GO:0034464) |
0.6 | 1.8 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.6 | 4.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.6 | 1.8 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.6 | 7.2 | GO:0032039 | integrator complex(GO:0032039) |
0.6 | 3.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.6 | 2.3 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.6 | 1.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.6 | 3.5 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.6 | 6.9 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.6 | 4.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.6 | 5.1 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.6 | 1.7 | GO:0030891 | VCB complex(GO:0030891) |
0.6 | 3.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.6 | 1.7 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.6 | 5.0 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.5 | 6.0 | GO:0008278 | cohesin complex(GO:0008278) |
0.5 | 5.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.5 | 5.9 | GO:0030897 | HOPS complex(GO:0030897) |
0.5 | 1.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.5 | 1.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.5 | 2.1 | GO:0016589 | NURF complex(GO:0016589) |
0.5 | 3.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.5 | 2.6 | GO:0000125 | PCAF complex(GO:0000125) |
0.5 | 2.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.5 | 7.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.5 | 8.2 | GO:0005844 | polysome(GO:0005844) |
0.5 | 2.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.5 | 5.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.5 | 32.7 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.5 | 6.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.5 | 34.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.5 | 3.5 | GO:0042555 | MCM complex(GO:0042555) |
0.5 | 25.9 | GO:0016605 | PML body(GO:0016605) |
0.5 | 10.0 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.5 | 5.5 | GO:0030663 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
0.5 | 5.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.5 | 1.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.5 | 4.4 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.5 | 3.9 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.5 | 6.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.5 | 3.9 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.5 | 1.9 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.5 | 8.2 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.5 | 1.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.5 | 1.0 | GO:0038201 | TORC1 complex(GO:0031931) TOR complex(GO:0038201) |
0.5 | 2.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.5 | 3.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.5 | 5.6 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.5 | 5.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.5 | 1.9 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.5 | 1.4 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.5 | 0.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.5 | 2.3 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.5 | 1.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.5 | 5.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.5 | 1.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.5 | 4.5 | GO:0031519 | PcG protein complex(GO:0031519) |
0.5 | 20.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.5 | 2.7 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.5 | 1.8 | GO:0002178 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.5 | 1.4 | GO:0032009 | early phagosome(GO:0032009) |
0.4 | 1.3 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.4 | 2.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.4 | 3.9 | GO:0016272 | prefoldin complex(GO:0016272) |
0.4 | 0.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 2.6 | GO:0031201 | SNARE complex(GO:0031201) |
0.4 | 17.0 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.4 | 1.3 | GO:0031090 | organelle membrane(GO:0031090) |
0.4 | 1.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.4 | 1.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.4 | 5.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.4 | 1.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.4 | 2.1 | GO:0008091 | spectrin(GO:0008091) |
0.4 | 37.4 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.4 | 3.7 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.4 | 1.2 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.4 | 1.2 | GO:0032059 | bleb(GO:0032059) |
0.4 | 14.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.4 | 2.9 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.4 | 2.9 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.4 | 3.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.4 | 1.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 2.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.4 | 1.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.4 | 12.6 | GO:0015030 | Cajal body(GO:0015030) |
0.4 | 6.9 | GO:0035097 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.4 | 6.1 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.4 | 8.7 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.4 | 16.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.4 | 5.9 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.4 | 2.7 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.4 | 1.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.4 | 10.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.4 | 10.8 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.4 | 12.7 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.4 | 0.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.4 | 9.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.4 | 1.5 | GO:0045179 | apical cortex(GO:0045179) |
0.4 | 2.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.4 | 26.3 | GO:0016607 | nuclear speck(GO:0016607) |
0.4 | 4.6 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.4 | 29.3 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.4 | 2.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 3.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.4 | 1.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.4 | 27.3 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.4 | 46.4 | GO:0005769 | early endosome(GO:0005769) |
0.4 | 4.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.4 | 1.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.4 | 64.1 | GO:0000785 | chromatin(GO:0000785) |
0.4 | 2.9 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.4 | 1.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.4 | 1.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.4 | 0.4 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.4 | 1.8 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.4 | 0.4 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.4 | 1.8 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.4 | 1.8 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.4 | 6.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.4 | 1.1 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.4 | 13.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.4 | 0.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.4 | 7.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.3 | 2.8 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.3 | 0.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 12.5 | GO:0030496 | midbody(GO:0030496) |
0.3 | 1.7 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.3 | 2.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.3 | 1.0 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 2.0 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.3 | 4.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 9.1 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 0.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.3 | 31.7 | GO:0005840 | ribosome(GO:0005840) |
0.3 | 2.6 | GO:0045259 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) proton-transporting ATP synthase complex(GO:0045259) |
0.3 | 12.8 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.3 | 1.3 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.3 | 1.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 1.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 6.6 | GO:0070469 | respiratory chain(GO:0070469) |
0.3 | 0.6 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.3 | 3.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.3 | 0.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 1.2 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) |
0.3 | 22.1 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 3.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.3 | 4.6 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 2.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.3 | 0.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 1.2 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.3 | 7.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.3 | 2.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 4.6 | GO:0098798 | mitochondrial protein complex(GO:0098798) |
0.3 | 0.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 6.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 0.9 | GO:0071986 | Ragulator complex(GO:0071986) |
0.3 | 2.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 2.0 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 205.4 | GO:0005730 | nucleolus(GO:0005730) |
0.3 | 0.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.3 | 0.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 1.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 0.8 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.3 | 1.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 1.6 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.3 | 1.3 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.3 | 1.0 | GO:0002102 | podosome(GO:0002102) |
0.3 | 5.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.3 | 0.5 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.3 | 1.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.3 | 1.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.3 | 14.7 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.3 | 1.5 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 1.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 0.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 17.5 | GO:0010008 | endosome membrane(GO:0010008) |
0.2 | 1.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 15.2 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.2 | 3.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 18.1 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 0.7 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 249.8 | GO:0005829 | cytosol(GO:0005829) |
0.2 | 0.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 3.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 164.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 2.4 | GO:0005884 | actin filament(GO:0005884) |
0.2 | 3.0 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 1.0 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.2 | 0.8 | GO:0016591 | DNA-directed RNA polymerase complex(GO:0000428) DNA-directed RNA polymerase II, holoenzyme(GO:0016591) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.2 | 0.6 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.2 | 2.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 1.0 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.4 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 3.4 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 1.8 | GO:0019867 | outer membrane(GO:0019867) |
0.2 | 13.2 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.2 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 7.5 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.2 | 1.0 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.2 | 488.6 | GO:0005634 | nucleus(GO:0005634) |
0.2 | 0.7 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 10.8 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.2 | 3.7 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.2 | 0.5 | GO:0031088 | platelet dense granule membrane(GO:0031088) platelet dense granule(GO:0042827) |
0.2 | 0.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 1.8 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.2 | 0.8 | GO:0016234 | inclusion body(GO:0016234) |
0.2 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 45.8 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.1 | 0.8 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 2.4 | GO:0072372 | primary cilium(GO:0072372) |
0.1 | 0.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 1.0 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.5 | GO:0033011 | perinuclear theca(GO:0033011) |
0.1 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 1.0 | GO:1990234 | transferase complex(GO:1990234) |
0.1 | 0.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 1.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.3 | GO:0031975 | envelope(GO:0031975) |
0.1 | 8.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.8 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.6 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 1.2 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.1 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.1 | 0.5 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 4.6 | GO:0070013 | intracellular organelle lumen(GO:0070013) |
0.1 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 9.0 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 1.6 | GO:0005768 | endosome(GO:0005768) |
0.1 | 4.5 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 7.3 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.1 | 0.1 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.1 | 0.1 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.1 | 1.7 | GO:0005929 | cilium(GO:0005929) |
0.1 | 0.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.1 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 6.6 | GO:0044431 | Golgi apparatus part(GO:0044431) |
0.0 | 79.2 | GO:0005622 | intracellular(GO:0005622) |
0.0 | 0.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 1.5 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.0 | 0.4 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
0.0 | 0.1 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 1.5 | GO:0001012 | transcription regulatory region sequence-specific DNA binding(GO:0000976) RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
1.4 | 4.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.3 | 5.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.3 | 4.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.3 | 3.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.3 | 1.3 | GO:0045159 | myosin II binding(GO:0045159) |
1.2 | 3.6 | GO:0003896 | DNA primase activity(GO:0003896) |
1.1 | 3.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
1.1 | 4.5 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.1 | 5.6 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
1.1 | 3.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.1 | 3.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.1 | 3.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.1 | 3.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
1.1 | 6.4 | GO:0005521 | lamin binding(GO:0005521) |
1.0 | 3.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.0 | 3.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.0 | 1.0 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
1.0 | 6.0 | GO:0008312 | 7S RNA binding(GO:0008312) |
1.0 | 3.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
1.0 | 3.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
1.0 | 2.0 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
1.0 | 3.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
1.0 | 1.0 | GO:0050693 | LBD domain binding(GO:0050693) |
1.0 | 2.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.0 | 2.9 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.9 | 2.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.9 | 5.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.9 | 2.7 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.9 | 5.3 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.9 | 3.5 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.9 | 2.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.9 | 2.6 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.9 | 0.9 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.9 | 2.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.9 | 0.9 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.9 | 2.6 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.9 | 2.6 | GO:0032357 | single guanine insertion binding(GO:0032142) oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.9 | 2.6 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.9 | 2.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.8 | 2.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.8 | 3.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.8 | 3.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.8 | 3.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.8 | 5.0 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.8 | 2.5 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.8 | 2.4 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.8 | 5.7 | GO:0015232 | heme transporter activity(GO:0015232) |
0.8 | 4.9 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.8 | 2.4 | GO:0046980 | tapasin binding(GO:0046980) |
0.8 | 5.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.8 | 1.6 | GO:0070061 | fructose binding(GO:0070061) |
0.8 | 4.7 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.8 | 3.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.8 | 5.5 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.8 | 2.3 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.8 | 3.9 | GO:0034452 | dynactin binding(GO:0034452) |
0.8 | 19.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.8 | 3.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.8 | 4.6 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.8 | 3.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.8 | 2.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.8 | 6.1 | GO:0005522 | profilin binding(GO:0005522) |
0.8 | 1.5 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.8 | 4.5 | GO:0061630 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.7 | 9.0 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.7 | 3.7 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.7 | 7.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.7 | 2.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.7 | 2.2 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.7 | 3.7 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.7 | 2.9 | GO:0031491 | nucleosome binding(GO:0031491) |
0.7 | 2.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.7 | 2.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.7 | 2.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.7 | 4.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.7 | 2.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.7 | 0.7 | GO:0035197 | siRNA binding(GO:0035197) |
0.7 | 7.1 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.7 | 2.1 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.7 | 2.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.7 | 0.7 | GO:0045502 | dynein binding(GO:0045502) |
0.7 | 2.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.7 | 2.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.7 | 2.1 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.7 | 3.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.7 | 3.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.7 | 0.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.7 | 2.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.7 | 2.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.7 | 3.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.7 | 3.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.7 | 5.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.7 | 4.1 | GO:0015288 | porin activity(GO:0015288) |
0.7 | 2.0 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.7 | 2.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.7 | 2.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.7 | 3.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.7 | 2.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.7 | 2.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.7 | 2.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.6 | 18.8 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.6 | 1.9 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.6 | 5.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.6 | 7.8 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.6 | 1.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.6 | 4.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.6 | 1.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.6 | 2.5 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.6 | 1.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.6 | 14.0 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.6 | 2.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.6 | 4.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.6 | 1.9 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.6 | 5.0 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.6 | 9.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.6 | 0.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.6 | 7.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.6 | 4.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.6 | 4.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.6 | 11.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.6 | 1.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.6 | 3.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.6 | 3.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.6 | 0.6 | GO:0046979 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.6 | 1.2 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.6 | 1.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.6 | 4.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.6 | 9.7 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.6 | 0.6 | GO:0070888 | E-box binding(GO:0070888) |
0.6 | 1.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.6 | 1.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.6 | 1.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.6 | 3.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.6 | 1.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.6 | 0.6 | GO:0060589 | nucleoside-triphosphatase regulator activity(GO:0060589) |
0.6 | 3.5 | GO:0070513 | death domain binding(GO:0070513) |
0.6 | 2.3 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.6 | 9.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.6 | 2.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.6 | 4.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.6 | 2.9 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.6 | 1.7 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.6 | 4.6 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.6 | 1.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.6 | 1.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.6 | 4.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.6 | 1.7 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.6 | 0.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.6 | 14.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.6 | 0.6 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.6 | 33.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.6 | 3.9 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.6 | 3.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.5 | 2.7 | GO:0015923 | mannosidase activity(GO:0015923) |
0.5 | 2.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.5 | 1.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.5 | 4.9 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.5 | 9.2 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.5 | 8.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.5 | 3.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 1.6 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.5 | 3.2 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.5 | 1.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.5 | 2.6 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.5 | 10.0 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.5 | 2.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.5 | 1.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.5 | 5.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.5 | 2.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.5 | 2.6 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.5 | 2.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.5 | 5.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.5 | 2.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.5 | 3.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.5 | 0.5 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.5 | 0.5 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.5 | 2.0 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.5 | 2.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.5 | 4.5 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.5 | 0.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.5 | 1.0 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.5 | 2.5 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.5 | 1.5 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.5 | 2.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.5 | 2.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.5 | 0.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.5 | 6.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.5 | 1.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.5 | 4.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.5 | 3.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.5 | 5.7 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.5 | 0.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.5 | 1.9 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.5 | 1.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.5 | 36.9 | GO:0008565 | protein transporter activity(GO:0008565) |
0.5 | 14.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.5 | 8.4 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) ubiquitin binding(GO:0043130) |
0.5 | 0.5 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.5 | 2.8 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.5 | 1.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.5 | 1.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.5 | 1.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.5 | 2.7 | GO:0031996 | thioesterase binding(GO:0031996) |
0.5 | 2.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.5 | 2.7 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.5 | 4.1 | GO:0005048 | signal sequence binding(GO:0005048) |
0.5 | 1.4 | GO:0043495 | protein anchor(GO:0043495) |
0.5 | 3.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.5 | 1.4 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.5 | 0.9 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.4 | 0.9 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.4 | 38.5 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.4 | 1.8 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.4 | 1.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 4.5 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.4 | 3.1 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.4 | 0.4 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.4 | 0.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.4 | 0.9 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.4 | 4.0 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.4 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 1.8 | GO:0035173 | histone kinase activity(GO:0035173) |
0.4 | 15.8 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.4 | 57.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.4 | 1.7 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.4 | 1.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.4 | 2.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 0.4 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.4 | 1.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.4 | 3.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 3.4 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.4 | 1.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.4 | 1.7 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.4 | 0.4 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.4 | 1.7 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.4 | 0.4 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.4 | 0.4 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.4 | 2.9 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.4 | 2.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.4 | 9.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.4 | 0.8 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.4 | 2.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.4 | 1.2 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.4 | 13.1 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.4 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.4 | 9.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.4 | 7.3 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.4 | 1.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.4 | 2.4 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.4 | 3.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 9.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.4 | 3.6 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.4 | 0.4 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.4 | 5.1 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.4 | 15.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.4 | 1.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.4 | 0.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.4 | 0.8 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.4 | 3.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.4 | 0.4 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.4 | 2.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.4 | 1.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 1.2 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.4 | 0.4 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.4 | 1.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.4 | 1.9 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 1.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.4 | 6.1 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.4 | 0.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.4 | 34.6 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.4 | 1.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.4 | 1.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.4 | 4.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.4 | 7.6 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.4 | 1.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.4 | 1.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.4 | 0.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.4 | 3.8 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.4 | 6.4 | GO:0002039 | p53 binding(GO:0002039) |
0.4 | 3.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.4 | 0.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.4 | 2.6 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.4 | 1.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.4 | 0.4 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.4 | 2.2 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.4 | 2.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.4 | 1.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.4 | 1.5 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.4 | 3.7 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.4 | 5.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 1.8 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.4 | 1.8 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.4 | 1.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.4 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.4 | 7.5 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.4 | 0.4 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.4 | 1.1 | GO:0004739 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.4 | 0.7 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.4 | 4.3 | GO:0043621 | protein self-association(GO:0043621) |
0.4 | 2.5 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.4 | 0.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.4 | 3.2 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.4 | 16.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.3 | 2.8 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.3 | 1.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 2.8 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.3 | 9.0 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.3 | 45.6 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.3 | 5.8 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.3 | 6.5 | GO:0042393 | histone binding(GO:0042393) |
0.3 | 16.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 0.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.3 | 5.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.3 | 3.1 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.3 | 1.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 1.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 6.7 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.3 | 5.1 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.3 | 1.0 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.3 | 8.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.3 | 1.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.3 | 1.0 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.3 | 0.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 1.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 11.4 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.3 | 1.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 1.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.3 | 1.6 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.3 | 7.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.3 | 2.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 0.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.3 | 1.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 1.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 0.6 | GO:0000339 | RNA cap binding(GO:0000339) |
0.3 | 3.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.3 | 4.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 1.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.3 | 0.9 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.3 | 0.3 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.3 | 2.5 | GO:0030515 | snoRNA binding(GO:0030515) |
0.3 | 0.6 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.3 | 3.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.3 | 0.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.3 | 0.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.3 | 0.9 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 3.4 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.3 | 7.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 1.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 2.8 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.3 | 0.6 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.3 | 4.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 0.9 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.3 | 2.7 | GO:0019213 | deacetylase activity(GO:0019213) |
0.3 | 0.3 | GO:0004875 | complement receptor activity(GO:0004875) |
0.3 | 7.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 7.8 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.3 | 126.3 | GO:0003723 | RNA binding(GO:0003723) |
0.3 | 1.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.3 | 3.2 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.3 | 1.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 1.2 | GO:0019894 | kinesin binding(GO:0019894) |
0.3 | 0.9 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 11.9 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.3 | 2.0 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.3 | 1.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 0.9 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.3 | 1.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 6.3 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.3 | 0.9 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 2.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 0.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 0.6 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.3 | 8.4 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.3 | 51.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.3 | 0.6 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.3 | 1.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.3 | 3.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 2.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.3 | 1.4 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.3 | 1.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 1.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.3 | 0.3 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.3 | 1.4 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.3 | 3.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.3 | 9.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 0.5 | GO:0016208 | AMP binding(GO:0016208) |
0.3 | 1.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.3 | 3.4 | GO:0005035 | death receptor activity(GO:0005035) |
0.3 | 0.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 7.6 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.3 | 1.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.3 | 0.8 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 3.3 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.3 | 0.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 3.3 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.3 | 0.3 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.3 | 0.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 1.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.3 | 1.5 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 0.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 14.5 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.2 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 1.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 3.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 3.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 1.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 1.5 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 1.7 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.2 | 2.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.2 | 1.9 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.2 | 2.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 1.7 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 0.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.2 | 0.5 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.2 | 0.7 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 0.5 | GO:0045569 | TRAIL binding(GO:0045569) |
0.2 | 0.7 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 0.2 | GO:0034618 | nitric-oxide synthase activity(GO:0004517) arginine binding(GO:0034618) |
0.2 | 2.1 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.2 | 1.6 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 0.2 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.2 | 1.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 0.7 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 1.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.2 | 1.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 0.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 2.7 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.2 | 2.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 0.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 1.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 331.0 | GO:0008270 | zinc ion binding(GO:0008270) |
0.2 | 3.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 1.1 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.2 | 0.7 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.2 | 0.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 1.5 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.2 | 0.2 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.2 | 0.7 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 0.7 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 2.8 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.2 | 1.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 0.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 0.9 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 2.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 0.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 1.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 0.4 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.2 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 3.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 0.2 | GO:0000036 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.2 | 0.4 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.2 | 4.6 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.2 | 0.8 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 1.4 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 26.5 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 4.9 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.2 | 0.6 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.2 | 0.4 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.2 | 5.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 0.6 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.2 | 1.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 0.8 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 0.8 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 3.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 1.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 0.9 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.2 | 34.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 1.9 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.2 | 0.6 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 2.4 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.2 | 0.4 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.2 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 0.2 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.2 | 0.9 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.2 | 1.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 0.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 0.9 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 0.9 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.2 | 2.0 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.2 | 6.0 | GO:0004386 | helicase activity(GO:0004386) |
0.2 | 0.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.7 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 0.2 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 1.8 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.2 | 1.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 1.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 2.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 3.8 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.2 | 1.9 | GO:0004527 | exonuclease activity(GO:0004527) |
0.2 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.2 | 24.9 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.2 | 0.3 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.2 | 0.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 1.7 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.2 | 0.5 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 0.6 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 5.5 | GO:0004518 | nuclease activity(GO:0004518) |
0.2 | 0.5 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 1.8 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.2 | 0.8 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.2 | 0.2 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.2 | 0.2 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.2 | 0.5 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.2 | 0.6 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.2 | 0.2 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.2 | 0.2 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.2 | 0.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 1.2 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.2 | 0.3 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.2 | 1.1 | GO:1990782 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.2 | 0.3 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 1.1 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.2 | 1.2 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.2 | 1.4 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.2 | 0.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 0.5 | GO:0032451 | demethylase activity(GO:0032451) |
0.2 | 2.7 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.2 | 1.8 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.2 | 0.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 3.0 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.3 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.1 | 1.9 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.6 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 0.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.7 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.4 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.3 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.7 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.7 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.3 | GO:0016741 | transferase activity, transferring one-carbon groups(GO:0016741) |
0.1 | 0.8 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 11.6 | GO:0050662 | coenzyme binding(GO:0050662) |
0.1 | 2.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.5 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 1.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.3 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 2.2 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 4.3 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.1 | 1.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.8 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 1.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 1.1 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 10.3 | GO:0019900 | kinase binding(GO:0019900) |
0.1 | 0.5 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 10.5 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 14.9 | GO:0005524 | ATP binding(GO:0005524) |
0.1 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 26.9 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.3 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 4.2 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.5 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.1 | 0.3 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.9 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.1 | 24.9 | GO:0017111 | nucleoside-triphosphatase activity(GO:0017111) |
0.1 | 5.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 2.1 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 3.2 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.2 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 2.5 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.1 | 4.2 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.1 | 1.1 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.6 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.1 | 1.3 | GO:0017016 | Ras GTPase binding(GO:0017016) |
0.1 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.4 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.8 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 1.8 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.1 | 1.8 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 0.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.3 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.1 | 0.6 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.4 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 2.3 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.1 | 0.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 1.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 1.5 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 1.5 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.1 | 0.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.8 | GO:0016772 | transferase activity, transferring phosphorus-containing groups(GO:0016772) |
0.1 | 0.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.2 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 1.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 2.9 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.1 | 4.0 | GO:0016564 | obsolete transcription repressor activity(GO:0016564) |
0.1 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.6 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.4 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 179.0 | GO:0005515 | protein binding(GO:0005515) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.0 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.1 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 6.3 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 14.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.9 | 11.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.9 | 19.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.8 | 12.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.8 | 42.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.8 | 5.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.8 | 0.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.7 | 5.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.7 | 12.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.7 | 14.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.7 | 0.7 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.6 | 1.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.6 | 16.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.6 | 18.9 | PID FOXO PATHWAY | FoxO family signaling |
0.6 | 12.0 | PID IFNG PATHWAY | IFN-gamma pathway |
0.6 | 18.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.6 | 8.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.6 | 6.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.5 | 4.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.5 | 8.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.5 | 1.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.5 | 7.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.5 | 3.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.5 | 9.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.5 | 7.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.5 | 12.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.5 | 3.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.5 | 11.9 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.5 | 1.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.5 | 6.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 7.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.5 | 5.7 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.5 | 18.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.5 | 6.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.5 | 13.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.5 | 10.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.4 | 8.9 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.4 | 9.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.4 | 5.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.4 | 10.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.4 | 1.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.4 | 2.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.4 | 0.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.4 | 3.7 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.4 | 2.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.4 | 5.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.4 | 25.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.4 | 2.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 9.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.4 | 1.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.4 | 4.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 5.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.4 | 5.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 11.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 3.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 3.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 10.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 1.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 2.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 3.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.3 | 6.4 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 5.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 0.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 14.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 3.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 8.4 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 2.8 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 10.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 1.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 4.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 2.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.3 | 9.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 6.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 5.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 7.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.3 | 1.8 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 1.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 3.6 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.2 | 3.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 4.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 1.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 0.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 3.6 | PID ATM PATHWAY | ATM pathway |
0.2 | 2.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 3.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 4.4 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 0.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 2.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 4.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 1.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 0.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 3.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 2.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 3.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 5.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 0.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 0.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 1.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.2 | 1.0 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 1.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.6 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 3.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 7.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 2.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 1.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 5.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 2.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 2.0 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 2.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 1.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
1.2 | 15.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.0 | 15.5 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.9 | 0.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.9 | 10.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.9 | 7.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.9 | 1.7 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.8 | 2.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.8 | 1.7 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.8 | 6.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.8 | 11.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.8 | 1.6 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.8 | 21.5 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.8 | 5.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.8 | 12.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.8 | 0.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.7 | 5.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.7 | 6.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.7 | 5.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.7 | 19.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.7 | 2.1 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.7 | 2.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.7 | 10.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.7 | 5.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.6 | 5.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.6 | 7.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.6 | 9.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.6 | 4.4 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.6 | 9.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.6 | 9.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.6 | 0.6 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.6 | 15.2 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.6 | 12.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.6 | 1.8 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.6 | 11.0 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.6 | 8.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.6 | 4.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.6 | 8.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.6 | 8.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.6 | 3.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.6 | 6.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.5 | 4.3 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.5 | 32.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.5 | 5.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.5 | 13.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.5 | 4.7 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.5 | 3.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.5 | 5.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.5 | 25.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.5 | 0.5 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.5 | 11.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.5 | 45.9 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.5 | 3.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.5 | 3.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.5 | 3.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.5 | 5.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.5 | 13.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.5 | 2.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.5 | 6.2 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.5 | 8.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.5 | 1.9 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.5 | 6.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.5 | 12.2 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.5 | 9.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.5 | 22.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.5 | 6.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.5 | 6.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.4 | 3.1 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.4 | 53.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.4 | 8.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.4 | 5.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.4 | 8.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.4 | 4.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 27.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.4 | 6.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.4 | 3.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 0.4 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.4 | 7.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.4 | 4.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.4 | 3.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.4 | 21.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.4 | 3.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 3.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.4 | 16.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.4 | 3.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.4 | 8.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.4 | 1.7 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.4 | 3.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.4 | 9.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.4 | 3.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.4 | 4.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.4 | 6.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.4 | 4.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.4 | 6.7 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.4 | 3.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.4 | 1.2 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.4 | 0.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.4 | 2.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.4 | 6.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.4 | 8.7 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.4 | 4.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.4 | 9.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.4 | 6.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.4 | 6.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.4 | 7.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.4 | 3.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.4 | 5.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.4 | 5.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.4 | 1.5 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.4 | 1.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 2.9 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.4 | 3.2 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.3 | 1.0 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.3 | 3.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 4.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 16.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 7.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 6.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 3.0 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.3 | 2.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.3 | 100.5 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.3 | 3.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 3.5 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.3 | 6.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.3 | 4.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 1.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.3 | 4.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 3.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 4.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 11.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.3 | 1.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 8.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 4.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.3 | 2.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.3 | 2.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.3 | 3.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 5.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.3 | 2.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 2.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.3 | 0.3 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.3 | 1.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.3 | 3.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.3 | 2.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.3 | 4.1 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.3 | 26.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 1.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 3.5 | REACTOME TRANSLATION | Genes involved in Translation |
0.3 | 0.3 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.3 | 1.5 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.3 | 4.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 0.5 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.2 | 0.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 1.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 0.5 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 8.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 2.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.2 | 4.6 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 11.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 0.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 6.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 0.7 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.2 | 3.8 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 2.6 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.2 | 3.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 6.5 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
0.2 | 14.5 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.2 | 3.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 1.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 3.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 3.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 4.5 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.2 | 0.9 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.2 | 8.7 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.2 | 2.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 0.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 3.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 2.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 1.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 1.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 5.2 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.2 | 3.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 7.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.2 | 0.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 2.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 1.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 2.0 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 5.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 0.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 1.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 0.3 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 1.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 1.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.7 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 0.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 3.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 1.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 1.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 3.5 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 0.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.7 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.2 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.1 | 0.4 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 1.0 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.1 | 0.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 1.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 1.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.2 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 4.6 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |